Comparative Effectiveness of Telaprevir-Based Triple Therapy in Patients With Chronic Hepatitis C

Telaprevir-based triple therapy in clinical practice is considerably more effective than dual therapy with p-IFN and RBV despite the significant degree of anemia that complicated therapy, requiring RBV dose reduction and erythropoietin support.